Aromatase in Human Breast Carcinoma as a Key Regulator of Intratumoral Sex Steroid Concentrations-Reference-Cited by-同舟云学术

Aromatase in Human Breast Carcinoma as a Key Regulator of Intratumoral Sex Steroid Concentrations

Published:2008 Issue:3 Volume:55 Page:455-463
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

SUZUKI Takashi¹,MIKI Yasuhiro²,AKAHIRA Jun-ichi²,MORIYA Takuya³,OHUCHI Noriaki⁴,SASANO Hironobu²

Affiliation:

1. Department of Pathology, Tohoku University School of Health Sciences

2. Department of Pathology, Tohoku University School of Medicine

3. Department of Pathology 2, Kawasaki Medical School

4. Department of Surgical Oncology, Tohoku University School of Medicine

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/55/3/55_K07E-053/_pdf

Reference57 articles.

1. 1. Robertson JF, Blamey RW (2003) The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women. Eur J Cancer 39: 861-869.

2. 2. Eneman JD, Wood ME, Muss HB (2004) Selecting adjuvant endocrine therapy for breast cancer. Oncology (Huntingt) 18: 1733-1744, discussion 1744-1744, 1748, 1751-1754.

3. Intratumoral Aromatase in Human Breast, Endometrial, and Ovarian Malignancies

4. Aromatase activity in breast tissue

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus-Faced Manner;Current Oncology;2024-08-24

2. Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies;Biochemical Pharmacology;2024-05

3. DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care;Cancers;2024-04-19

4. Rs10046, Rs1902023, Rs4148269 and Ugt2b17 Deletion in Tunisian Women's Hormone Receptor Positivebreast Cancer: Risk Factors and Prognostic;2023

5. Estrogen receptor-positive (ER+) breast cancer treatment: Are multi-target compounds the next promising approach?;Biochemical Pharmacology;2020-07